Peter Damm Selected Research

Insulin Aspart (NovoLog)

1/2021	CopenFast trial: Faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy and lactation - a randomised controlled trial.
1/2014	A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes.
1/2014	Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester.
10/2012	Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes.
9/2011	Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes.
3/2010	Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study.
2/2008	Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Damm Research Topics

Disease

50	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2022 - 05/2003
31	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2022 - 07/2007
24	Type 2 Diabetes Mellitus (MODY) 02/2022 - 01/2005
22	Insulin Resistance 01/2022 - 07/2005
21	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2006
10	Hypoglycemia (Reactive Hypoglycemia) 05/2022 - 01/2008
9	Gestational Weight Gain 01/2021 - 09/2005
8	Overweight 02/2022 - 07/2003
8	Glucose Intolerance 01/2022 - 05/2004
6	Obesity 02/2022 - 07/2003
6	Birth Weight (Birth Weights) 10/2014 - 01/2003
5	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 02/2011
5	Hyperglycemia 04/2019 - 02/2008
5	Diabetic Nephropathies (Diabetic Nephropathy) 12/2012 - 05/2003
4	Prediabetic State (Prediabetes) 02/2022 - 05/2015
4	Pregnancy Complications 01/2019 - 01/2008
3	Perinatal Death 05/2022 - 01/2017
3	Stillbirth 01/2021 - 05/2003
3	Heart Failure 12/2017 - 12/2005
3	Shoulder Dystocia 10/2015 - 01/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2015 - 07/2005
3	Mason-Type Diabetes 03/2010 - 11/2004
2	Inflammation (Inflammations) 02/2022 - 12/2017
2	Nausea 01/2022 - 01/2008
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2022 - 01/2016
2	Asphyxia (Suffocation) 01/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 10/2020 - 01/2017
2	Weight Gain 01/2020 - 09/2005
2	Fatty Liver 11/2019 - 01/2019
2	Diabetes Mellitus 01/2019 - 01/2005
2	Malaria 01/2016 - 01/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 08/2012 - 02/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Placental Insufficiency 01/2022
1	Cardiomyopathies (Cardiomyopathy) 02/2021
1	Body Weight (Weight, Body) 10/2020
1	Fetal Weight 05/2020
1	Vitamin D Deficiency 01/2020
1	Ketosis 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	White Coat Hypertension 12/2019

Drug/Important Bio-Agent (IBA)

51	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 07/2003
25	Insulin (Novolin)FDA Link 02/2022 - 02/2008
15	Vitamin D FDA LinkGeneric 01/2021 - 07/2013
8	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2009
7	Insulin Aspart (NovoLog)FDA Link 01/2021 - 02/2008
6	Insulin Detemir (Levemir)FDA Link 01/2021 - 09/2011
6	CarbohydratesIBA 01/2020 - 05/2014
5	LipidsIBA 02/2022 - 07/2005
5	LeptinIBA 01/2020 - 01/2017
4	MicroRNAs (MicroRNA)IBA 02/2022 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2020
4	CreatinineIBA 02/2016 - 04/2006
3	Long-Acting Insulin (Insulin, Long Acting)FDA Link 05/2022 - 04/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 02/2011
3	Glucagon (Glukagon)FDA Link 01/2021 - 05/2015
3	C-PeptideIBA 01/2020 - 06/2009
3	AdiponectinIBA 12/2019 - 01/2017
3	Blood Glucose (Blood Sugar)IBA 05/2017 - 02/2008
3	Growth Hormone (Somatotropin)IBA 12/2015 - 01/2003
3	Protamines (Protamine Sulfate)FDA Link 01/2014 - 02/2008
3	Isophane Insulin (NPH Insulin)FDA Link 01/2014 - 09/2011
3	AlbuminsIBA 12/2012 - 04/2006
2	insulin degludecIBA 05/2022 - 06/2019
2	Methyldopa (Aldomet)FDA LinkGeneric 01/2022 - 01/2016
2	AutoantibodiesIBA 01/2022 - 01/2008
2	InsulinsIBA 01/2021 - 01/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2020 - 05/2015
2	Glucagon-Like Peptide-1 ReceptorIBA 10/2020 - 10/2013
2	Insulin Glargine (Lantus)FDA Link 06/2019 - 04/2013
2	HDL CholesterolIBA 01/2019 - 12/2017
2	MargarineIBA 01/2018 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 12/2017 - 11/2006
2	Messenger RNA (mRNA)IBA 12/2017 - 11/2006
2	AdipokinesIBA 01/2017 - 01/2017
2	C-Reactive ProteinIBA 08/2012 - 09/2008
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2011 - 12/2005
1	CalciumIBA 01/2022
1	Prealbumin (Transthyretin)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Apolipoproteins D (Apo D)IBA 01/2022
1	P-2 (P 2)IBA 11/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2021
1	Hormones (Hormone)IBA 02/2021
1	EnzymesIBA 02/2021
1	Cathepsin DIBA 02/2021
1	ProlactinIBA 02/2021
1	Tyrosine (L-Tyrosine)FDA Link 02/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Liraglutide FDA Link 10/2020
1	hydroxide ionIBA 01/2020
1	fibroblast growth factor 21IBA 12/2019

Therapy/Procedure

14	Glycemic Control 01/2022 - 05/2003
9	Cesarean Section (Caesarean Section) 11/2021 - 07/2003
8	Therapeutics 01/2021 - 02/2008
2	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 06/2019 - 01/2015
2	Contraception (Birth Control) 07/2007 - 01/2005
2	Induced Labor 09/2005 - 07/2003